RxDoctor Payments Data

Samantha Fritch

Family · Bedford, INNPI 1558933762

Payments from drug & device makers

$2,480in general payments, 2019–2025

Across 140 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$484
  • Novartis$297
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$279
  • AstraZeneca$237
  • Otsuka America Pharmaceutical, Inc.$159
  • Novo Nordisk$141
  • plus $883 from 21 others

What the payments were for

  • Food & beverage$2,480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,480 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$52,195
MounjaroTirzepatide36$38,210
FarxigaDapagliflozin Propanediol28$27,941
EliquisApixaban39$21,465
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$13,989
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$13,905
JardianceEmpagliflozin12$8,568
Aripiprazole15$4,626
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,946
Albuterol Sulfate HfaAlbuterol Sulfate65$1,865
Gabapentin89$1,342
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$910
Atorvastatin Calcium144$761
Omeprazole75$688
Venlafaxine Hcl ErVenlafaxine Hcl21$648

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$141$52,19554 claims
AstraZenecaFarxiga, Breztri Aerosphere$237$41,84649 claims
Lilly USA, LLCMounjaro$484$38,21036 claims
PfizerEliquis$63$21,46539 claims
GSKTrelegy Ellipta$29$13,98914 claims
Boehringer IngelheimJardiance$58$8,56812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.

Other family in Bedford

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →